Abstract
The Oxazolidinones are a promising novel chemical synthetic class of antibiotics identified in the last two decades and have been subjected to intensive discovery efforts. They possess impressive antibacterial activity against Grampositive pathogens. Oxazolidinones act through a unique mechanism of inhibitory bacterial protein biosynthesis. Linezolid (ZyvoxTM) has been the only drug of oxazolidinone class to reach the market after USFDA approval. Here we review our efforts directed to the discovery of novel oxazolidinone antibacterials evolved through structure-activity relationship (SAR) and an overview of contemporary on going efforts.
Keywords: Oxazolidinones, Antibacterials, antibiotics, structure-activity relationship (SAR), antibacterial activity, synthetic compound
Anti-Infective Agents in Medicinal Chemistry
Title: Oxazolidinone Antibacterials and Our Experience
Volume: 7 Issue: 4
Author(s): Brijesh Kumar Srivastava, Rina Soni, Jayendra Z. Patel, Mukul R. Jain and Pankaj R. Patel
Affiliation:
Keywords: Oxazolidinones, Antibacterials, antibiotics, structure-activity relationship (SAR), antibacterial activity, synthetic compound
Abstract: The Oxazolidinones are a promising novel chemical synthetic class of antibiotics identified in the last two decades and have been subjected to intensive discovery efforts. They possess impressive antibacterial activity against Grampositive pathogens. Oxazolidinones act through a unique mechanism of inhibitory bacterial protein biosynthesis. Linezolid (ZyvoxTM) has been the only drug of oxazolidinone class to reach the market after USFDA approval. Here we review our efforts directed to the discovery of novel oxazolidinone antibacterials evolved through structure-activity relationship (SAR) and an overview of contemporary on going efforts.
Export Options
About this article
Cite this article as:
Srivastava Kumar Brijesh, Soni Rina, Patel Z. Jayendra, Jain R. Mukul and Patel R. Pankaj, Oxazolidinone Antibacterials and Our Experience, Anti-Infective Agents in Medicinal Chemistry 2008; 7 (4) . https://dx.doi.org/10.2174/187152108785908820
DOI https://dx.doi.org/10.2174/187152108785908820 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
Ghrelin as a Potential Anti-Obesity Target
Current Pharmaceutical Design Identifying the Structural Features of Diphenyl Ether Analogues for InhA Inhibition: A 2D and 3D QSAR Based Study
Letters in Drug Design & Discovery A Novel Multi-Target Drug Screening Strategy Directed Against Key Proteins of DAPk Family
Combinatorial Chemistry & High Throughput Screening Preface
Current Medical Imaging Optimization of Supercritical Fluid Extraction for <i>Mariposa Christia Vespertilionis</i> Leaves Towards Yield by Using Response Surface Methodology
Recent Innovations in Chemical Engineering Dysregulation of RNA Mediated Gene Expression in Motor Neuron Diseases
CNS & Neurological Disorders - Drug Targets The Application of Cell-Penetrating-Peptides in Antibacterial Agents
Current Medicinal Chemistry NAD(P) Biosynthesis Enzymes as Potential Targets for Selective Drug Design
Current Medicinal Chemistry Development of Linker-Conjugated Nanosize Lipid Vesicles: A Strategy for Cell Selective Treatment in Breast Cancer
Current Cancer Drug Targets Comparison of Protease Inhibitor (PI) Resistance-Associated Mutations Between PI-Naive and PI-Experienced HIV-1 Infected Patients in Thailand Where Subtype A/E is Predominant
Current HIV Research Synthesis and SAR Study of Simple Aryl Oximes and Nitrofuranyl Derivatives with Potent Activity Against Mycobacterium tuberculosis
Letters in Drug Design & Discovery Association of Pharmacokinetic and Pharmacodynamic Aspects of Linezolid with Infection Outcome
Current Drug Metabolism The Druggable Antimalarial Target PfDXR: Overproduction Strategies and Kinetic Characterization
Protein & Peptide Letters Cheminformatics Based Machine Learning Approaches for Assessing Glycolytic Pathway Antagonists of Mycobacterium tuberculosis
Combinatorial Chemistry & High Throughput Screening Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates
Anti-Cancer Agents in Medicinal Chemistry Investigation of Potential Inhibitors of Chorismate-Utilizing Enzymes
Current Medicinal Chemistry Novel Applications of Nanotechnology in Controlling HIV and HSV Infections
Current Drug Research Reviews Updated Acute Community-Acquired Pneumonia in Adults: Guidelines for Initial Antimicrobial Therapy Based on Local Evidence from the South American Working Group (Consensur II)
Current Respiratory Medicine Reviews Nanoembedded Microparticles for Stabilization and Delivery of Drug-Loaded Nanoparticles
Current Pharmaceutical Design Danger-Detector NKG2D: Immunosurveillance of Induced Self and Modulation by Cytokines and Soluble Ligands
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents